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ABSTRACT 
The effects of multiple toxic doses of methamphetamine on cate-
cholaminergic, serotonergic, and cholinergic metabolism in the neo-
striatum, nucleus accumbens, olfactory tubercle, and median emi-
nence area of the rat brain have been investigated. Methamphetamine 
(15 mg/kg, s.c.) was administered every 6 hours for 5 doses. Thirty-
six hours after the first of 5 doses, tyrosine hydroxylase (TH) ac-
tivity as well as dopamine and norepinephrine levels were signifi-
cantly decreased in the neostriatum and olfactory tubercle but were 
not altered in the nucleus accumbens or median eminence area. Prior 
to the 36-hour time point, drug treatment did significantly decrease 
TH activity in the neostriatum (at 3, 12, and 24 hour) and olfactory 
tubercle (at 24 hour) but did not change the enzyme activity in the 
nucleus accumbens. At 0.5, 7~ 15, and 30 days after 5 doses of meth-
amphetamine, TH activity in the neostriatum was significantly de-
creased by at least 38%. In the olfactory tubercle, TH activity was 
also significantly decreased at 0.5, 15, and 30 days but was not de-
creased at 7 days after the last dose. Only a slight change in TH 
activity occurred in the nucleus accumbens at 15 and 30 days after 
drug treatment. In contrast, tryptophan hydroxylase (TPH) activity 
was significantly decreased in the neostriatum, nucleus accumbens, 
and olfactory tubercle by 75% 3 hours after the first dose. TPH ac-
tivity rema'ined depressed, by at least 65%, at 30 days after the 
fifth dose in all 3 areas. Methamphetamine caused a slight decrease 
in choline acetyltransferase activity in olfactory tubercle at the 
36-hour time point; however, it did not affect cholinergic enzyme 
activity in the neostriatum or nucleus accumbens. This evidence sug-
gests that the serotonergic neurons are more sensitive to the toxic 
effects of methamphetamine than the dopaminergic neurons, whereas 
the cholinergic neurons seem to be unaffected. 
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INTRODUCTION 
Multiple intravenous injections of high doses of methamphetamine 
can cause psychotoxic reactions in humans. Individual doses ranging 
from 100-300 mg and as high as 1000 mg taken at a frequency of every 
2 hours or less for approximately 3 to 6 days have been reported 
(Kramer, Fischman and Littlefield, 1967). Manifestations of the 
psychotic behavior usually occur during the mid-portion of this dos-
age regimen and are described primarily as paranoid schizophrenia. 
The behavioral symptoms are distinguished by repetitive and compul-
sive behavior, hallucinations (auditory, visual and tactile), and 
delusions of persecution (Utena, 1966; Kramer et al., 1967; and 
Hofman, 1975). Amphetamine (or methamphetamine) psychosis has a du-
. ration of approximately a week. However, "residual behaviors" have 
been reported to exist for several months (Kramer et al., 1967) to 
a year after termination of drug usage (Utena, 1966) and include 
loss of initiative and ability to concentrate, impairment of memory, 
and apathy. It is noteworthy that both the paranoid schizophrenic 
and the methamphetamine-intoxicated individual are treated with anti-
psychotic drugs which are primarily dopamine antagonists (Espelin 
and Done, 1968; Byck, 1975). 
In order to determine what neurochemical changes may occur dur-
ing the paranoid schizophrenic period, as well as those occurring 
after cessation of the drug, our laboratory designed an animal model 
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where the dosage regimen 'lIas similar to that used by humans abusing 
methamphetamine intravenously_ Koda and Gibb (1973), Buening and 
Gibb (1974) and Kogan, Nichols and Gibb (1976) have used this model 
to show that multiple toxic doses of methamphetamine cause a decrease 
in tyrosine hydroxylase (TH) activity, and dopamine (DA), and nor~ 
epinephrine (NE) levels in the rat neostriatum. Buening and Gibb 
(1974) and Kogan et al. (1976) have reported that the methamphet-
amine-induced decrease in neostriatal TH activity and DA levels 
could be prevented by concurrent administration of haloperidol or 
ch1orpromazineo With this paradigm we have shown that methamphet-
amine also decreases neostriatal tryptophan hydroxylase (TPH) activ-
ity but does not affect choline acetyltransferase (ChAT) or glutamic 
acid decarboxylase (GAD) activities (Hotchkiss, Morgan and Gibb, 
1979). Furthermore, the neostriata1 TH and TPH activities were 
still significantly decreased 30 days after the last injection 
(Hotchkiss et al., 1979; Hotchkiss and Gibb, 1979). This work cor-
roborates the short-term studies of Knapp, r~andell, and Geyer (1974) 
and McGeer, Brewal1, and McGeer (1974) who demonstrated that meth-
amphetamine decreased neostr"iatal TPH activity but has no effect on 
ChAT activity. 
A number of investigations have suggested that the mesolimbic 
dopaminergic nuclei may playa role in amphetamine psychosis. When 
dopamine, apomorphine, or d-amphetamine was injected bilaterally in-
to the rat nucleus accumbens, an increase in locomotor activity was 
observed (Pijnenburg and van Rossum, 1973; Anden and Johnels, 1977; 
Jackson, And~n, an~ Dahlstr5m, 1975). Jackson et al. (1975) con-
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eluded that d-amphetamine was causing release of dopamine because 
the drug-induced increase in locomotor activity was prevented by a-
methy1-£-tyrosine or trifluoperazine, a TH inhibitor and a dopamine 
antagonist, respectively. Injection of haloperidol, a dopamine an-
tagonist, into the nucleus accumbens or unilateral lesions destroy-
ing the olfactory tubercle and part of the nucleus accumbens also 
blocked the amphetamine-induced hyperactivity or stereotypic behav-
ior, respectively (Pijnenburg, Honig and van Rossum, 1975; Yehuda 
and Wurtman, 1975). 
Using homovani11ic acid (HVA) levels for an index of dopamine 
turnover, Anden and Stock (1973) reported that clozapine caused an 
increase in HVA concentration to a greater extent in the limbic area 
than in the neostriatum. Zivkovic, Guidotti, Revuetta, and Costa 
(1975) have shown that haloperidol preferentially increased the af-
finity of neostriatal TH for the cofactor DMPH 4 , whereas clozapine 
does so in the nucleus accumbens. These investigators also reported 
that dopamine turnover was differentially affected by acute treat-
ment with haloperidol and clozapine. In concentrations which did 
not affect turnover in the neostriatum, clozapine caused an increase 
in turnover in the nucleus accumbens. Conversely, haloperidol in-
creased the turnover rate in the neostriatum but not in tbe nucleus 
accumbens. These studies suggest that the site of action of anti-
psychotic drugs which have a low potential for inducing extrapyra-
midal side effects may be in the mesolimbic brain regions. 
Kaneno, Watanabe, Toru, and Shimazono (1978) found that daily 
administration of chlorpromazine for 14 days increased neostriatal 
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dopamine-sensitive adenyl ate cyclase activity. However, in the nu-
cleus accumbens plus septal nuclei tissue samples, the activity was 
decreased, indicating that tolerance to chlorpromazine had occurred 
in the neostriatum but not in the nucleus accumbens. 
In this study we compared the effects of multiple toxic doses 
of methamphetamine on dopaminergic, noradrenergic, serotonergic, and 
cholinergic metabolism in the neostriatum, mesolimbic nuclei (nu-
cleus accumbens and olfactory tubercle), and the median eminence 
area of the rat brain in an attempt to broaden our understanding of 
the neurochemical changes induced by methamphetamine abuse. 
MATERIALS AND METHODS 
Male Sprague-Dawley rats weighing between 150-250 g were 
housed 3 per cage in a room with controlled lighting (6 a.m. to 
6 p.m.~ light; 6 pomo to 6 a.m. dark) and heating (24°C). Food and 
water were offered ad libitumo Dosage regimens and times of animal 
sacrifice are described in the Figure legends. 
Dissection Procedure 
Following decapitation, the whole brain was immediately removed 
from the cranium, chilled on ice and dissected on an ice-cold glass 
plate. With the ventral side up, 3 serial coronal sections of whole 
brain were made according to the following Konig and Klippel atlas 
coordinates (rostral to caudal side); 1,A10005~-A9820~ to A8620~­
A8380~; 2, A8620~-A8380~ to A7890~-A7470~; and 3, A4230~-A4110~ to 
A3750~-A3430~o The first coronal razor cut was made at the rostral 
border of the olfactory tubercle and the second' approximately 1.5 mm 
caudal. With the aid of a dissecting scope the nucleus accumbens 
was bilaterally dissected from the rostral side of this 1.5-mm sec-
tion. The neostriatum and olfactory tubercle were bilaterally dis-
sected from the second serial sectiono The lateral olfactory tracts 
were used as the lateral limits and a l-mm border caudal to the ven-
tral surface was used as a dorsal limit for the olfactory tubercle 
dissection. After removel of the olfactory tubercle, the remaining 
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tissue was cleared away and the neostriatum was collected. The me-
dian eminence was dissected from the third coronal slice. This dis-
section also contains arcuate nucleus and periv€ntricular nuclei. 
After dissection, the nuclei were wrapped in parafilm, frozen 
immediately on solid CO 2 and stored at -BO°C until assayed. This' 
procedure, from decapitation to freezing of the tissue samples, took 
4 minutes. The average tissue weights (10% mg protein/mg wet weight) 
were: neostriatum, 24.3 mg; nucleus accumbens, 1.61 mg; olfactory 
tubercle, 3.64 mg; and median eminence area, 0.53 mg. Protein mea-
surements were determined according to the method of Lowry (1951). 
Preparatory procedures prior to enzymatic incubation, including re-
agents, were performed at 0-5°C. 
Tyrosine Hydroxylase Assay 
The neostriatum was homogenized in 600 ~l, and the nucleus ac-
cumbens and olfactory tubercle were homogenized in 250 ~l of cold 
0.2% Triton X-100 in Kontes teflon-glass homogenizers (volume ca-
pacity, 100 ml). The median eminence from 3-4 animals were pooled 
and homogenized in 100 ~l of 0.2% cold Triton X-100 in Kontes ground-
glass homogenizers (volume capacity, 500 ~l). Aliquots were taken 
for protein determination and the homogenates were then centrifuged 
at 19,000 x ~ at 4°C after which the supernates were assayed for TH 
activity by the Nagatsu method (Nagatsu, Levitt, and Udenfriend, 
1964). In this procedure, L-[3,5- 3H] tyrosine was converted to ei-
ther the L-[5- 3H] or L-[3- 3H]dihydroxyphenylalanine and the dis-
placed tritium which equilibrates with water was counted by liquid 
scintillation spectroscopy. The reaction was linear up to 15 min-
utes. Purification of L-[3,5- 3H] tyrosine was performed according 
to Nagatsu (1973). 
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The total volume (100 vl for neostriatum, nucleus accumbens, and 
olfactory tubercle) of the reaction medium contained:0.4vCi L-[3, 
5- 3H] tyrosine (Amersham) dried under nitrogen gas; 10 nmoles L-ty-
rosine; 100 nmoles ferrous ammonium sulfate; 200 nmoles 2-amino-4-
hydroxy-6,7-dimethyl-5,6,7,8-tetrahydropteridine, DHPH 4 (Cal 8io-
chern); 10 ~moles 2-mercaptoethanol; 20 vmoles sodium acetate; and 50 
~l of tissue supernatant or 0.2% Triton X-100 for blanks. TH activ-
ity in the median eminence was assayed in a totaJ volume of 50 ~l 
and the reagent concentrations, as well as the volume of superna-
tant~ were one-half that described above. The final pH of the re-
action medium at 37°C was 6.0. 
The reaction medium was incubated for 15 minutes in a metabolic 
shaker at 250 rpm at 37°C, after which the enzyme reaction was ter-
minated with 100 vl of 10% trlchloroacetic acid (TCA). The acidified 
reaction mixture was transferred to a Dowex 50-H+ (200-400 mesh) col-
umn (0.5 x 2 cm). Each tube was rinsed with 1.0 ml glass-distilled 
water and transferred to the appropriate column after which an ad-
ditional 0.8 ml of glass-distilled water was added to the column. 
The combined total effluent of 20 0 ml was collected in a liquid 
scintillation vial to which 15 ml of scintillation fluid was added. 
Twenty-three grams of 2,5-diphenyloxazol (PPO), 1.0 liter of Triton 
X-100, and 2.0 liters of toluene made up the scintillation fluid. 
Radioactivity was counted in a Packard Tri-Carb Liquid Scintillation 
Spectrometer with an efficiency of 32%. 
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Tryptophan Hydroxylase Assay 
The neostriatum and mesolimbic nuclei were homogenized in 100 ~l 
and 35 ~l respectively, of 50 mM HEPES buffer (Sigma) containing 5 mM 
dithiothreotol. Kontes teflon-glass homogenizers (volume capacity, 
1.0 m1) were used for the homogenization of neostriatal tissue. 
Rodnot; ground-glass homogenizers (volume capacity of 100 ~l) were 
used to homogenize pooled (2-3) meso1imbic nuclei. The homogenates 
were centrifuged for 15 minutes at 19,000 x R at 4°C. TPH was as-
sayed in the supernatant by a modification of the procedure of 
Ichiyama, Nakamura, Nishizuka, and Hayaishi (1970), as described by 
Sitaram and Lees (1978), in which 14C02 is released from the radio-
active substrate tryptophan by L-aromatic amino acid decarboxylase 
(L-AAAD) and trapped on Hyamine hydroxide (Sigma) soaked filter pa-
pero The reaction was linear for at least 45 minutes. 
The total volume of the reaction mixture (1205 ~l) contained: 
13.3 nCi L-(1- 14C)-tryptophan, dried under nitrogen gas; 1.25 nmo1es 
L-(1-12C)-tryptophan; 240 nmoles HEPES buffer pH 7.4 at 25°C; 0.5 
nmoles pyridoxal phosphate; 10 nmoles 6MPH4 (absent in blanks) di-
luted 2:1 with a HEPES buffer (48 mM, pH 8.1) containing 480 mM mer-
captoethano1; 2.5 ~l (diluted 1:7.33) hog kidney L-AAAD, (partially 
purified by the method of Waymire, Buir, and Weiner, 1971) and 5 ~l 
of the tissue supernatant. The final pH was 7.4 at 37°Co 
The incubation of the reaction mixture and trapping of evolved 
CO2 was carried out in two separate tubes connected with a small 
piece of tightly fitting rubber tubing. Both vessels were of the 
same size, 6 x 50 mm test tubes. The reaction vessels were silanized. 
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In addition, the trapping vessels contained a piece of filter paper, 
8 x 15 rnm, to which 40 ~1 of Hyamine hydroxide had been added. Dur-
ing incubation, the tubes were held together in a vertical position 
with a small rubber bando 
Incubation of the reaction medium was at 37°C for 30 minutes, 
after which TPH activity was terminated by the addition of 100 ~l of 
5N H2S04 through the rubber tubing into the reaction vessel. The 
rubber bands were removed and the tubes were incubated in a hori-
zontal position at 37°C for 90 minutes during which time completion 
of CO2 trapping occurred. The trapping incubation was terminated by 
separating the reaction vessel from the trapping- vessel and trans-
ferring the filter paper to a Biovial (Beckman). The trapping ves-
sel was rinsed with 3.5 m1 of liquid scintillation cocktail (5 g 
PPO and 0.1 9 1,4-bis[2-(4-methyl-5-phenyloxazo1y1)]benzene, POPOP, 
per 1.0 liter toluene) and the combined rinse and filter paper were 
counted by liquid scintillation spectroscopy with an efficiency of 
85%. 
Choline Acety1transferase'Assay 
Choline acetyl transferase (ChAT) was measured by the procedure 
of Fonnum (1974). The tissue samples were homogenized 1:20 with 10 
mM EDTA) pH 7.4 in Kontes teflon-glass homogenizers (volume capacity, 
1.0 ml). An equal volume of 1.0% Triton X-100 was added to the homo-
genates to complete the solubilization of the enzyme. 
The total reaction mixture volume of 7.0 ~1 contained: 2100 
nmoles NaCl, 350 nmo1es sodium phosphate buffer pH 7.4, Og7 nmo1es 
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physostigmine (Sigma), 140 nmoles disodium ethylene diamine tetra-
acetate, 56 nmoles choline chloride, 0.01 ~Ci [3H]-acetYl-CoA (New 
England Nuclear), 1.4 nmoles acetyl-COA (Schwarz Mann) and 2 ~l of 
homogenate or 2 ~l of homogenizing solution for blanks. The reaction 
was linear for 20 minutes at 37°C and was carried out in a conical 
microtube, 5 x 20 mmo The reaction mixture was incubated at 37°C 
for 15 minutes after which ChAT activity was terminated by placing on 
ice and rinsing the microtube with 4.5 ml of a 10 mM sodium phos-
phate buffer, pH 7o~ into a liquid scintillation vial in which 2.0 
ml of an acetonitrite solution containing 0.5% kalignost (Sigma) and 
9.0 ml of liquid scintillation cocktail (5 g PPO~ O.lg POPOP per 
liter of toluene) had previously been dispensed. The phosphate buf-
fer was added with a repipetor with enough vigor to provide for suf-
ficient mixing of the reaction medium with the organic solvent phase. 
The radiolabeled product, acetylcholine, was extracted into the scin-
tillation phase by liquid cation exchange with kalignost, whereas 
the substrate, [3H]-acetyl-Co~, was partitioned into the aqueous 
phaseo Since the aqueous phase contained no scintillation solvent 
the unconverted substrate did not interfere with the scintillation 
counting of the producto The scintillation vials were placed in a 
LS 9000 Beckman scintillation spectrophotometer and counted after the 
samples had cooled and phase separation was completed (approximately 
10 minutes). Counting efficiency was 48%. 
Dopamine and NorepihephriheAssay 
Dopamine (DA) and norepinephrine (NE) were determined by a modi-
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fied radioenzymatic assay of Umezu and Moore (1979) as suggested by 
K.Eo Moore (personal communication) in which the respective sub-
strates v/ere methylated by par'tial purified catechol O-methyltrans-
ferase and S-adenosyl-L-[methyl-3H] methionine to 3-methoxytyramine 
and normetanephrine. The tritiated methylated products were then 
isolated by organic solvent extraction and separated by thin-layer 
chromatography. 
The neostriatum, nucleus accumbens, and olfactory tubercle were 
homogenized in 600, 100, and 150 ~l, respectively, of ice cold 0.2 N 
percho1oric acid containing 10 mg% ethylene glycol bis (s-aminoethyl-
ether)-N,N'-tetraacetic acid (EGTA). The homogenates were centri-
fuged at 5000 x ~ for 15 minutes at 4°C. 
The final reaction medium (35 ~l) contained: 1. 15 ~Ci S-adeno-
sy1-L-[methyl-3H]methionine (New England Nuclear); 706 ~l catechol 
O-methyltransferase, purified according to a modified procedure of 
Axelrod and Tomchick (1958) as described by Da Prada and ZUrcher 
(1976); 45.7 nmoles sodium ethyleneglycol-bis-(s-aminoethyl ether)N, 
N'-tetraacetic acid (EGTA), pH 7.2; 6.2 nmoles pargyline HC1, in 10% 
mercaptoethanol, freshly prepared; 9.8 nmoles Tris base containing 
29.6 nmoles MgC1 2 , pH 10.4 and 10 ~l of tissue extracts, standards 
or 0.2 N percholic acid containing 10 mg% EGTA for blanks o Standard 
curves ranged from 0~05-4 ng for DA and 0.005-0.4 ng for NE (free-
base, compounds obtained from Sigma). The reaction and organic sol-
vent extraction were performed in 10 x 75 nm glass disposable cul-
ture tubes. The mixture was incubated at 37°C for 60 minutes. The 
react i on was termi nated by p 1.aci ng the reacti on tubes on ice, add i ng 
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30 ~l of a 5:1 solution containing: 0.45 M borate buffer, pH 10 and 
a carrier solution containing 3-methoxytyramine and normetanephrine 
(5 mg/ml, free base, obtained from Sigma) and vortexing immediately. 
Five hundred and fifty 111 of a toluene:isopentyl alcohol (3:2) solu-
tion was dispensed into each tube, vortexed and centrifuged to sepa-
rate the aqueous and organic phases. Four hundred 111 of the organic 
phase was then transferred to 40 111 of ice cold 001 N Hel in dispos-
able glass culture tubes (10 x 75 mm), vortexed and centrifuged after 
which the aqueous phase was frozen in an acetone dry ice mixture and 
the organic phase was aspirated off. Twenty-five 111 of the aqueous 
phase was then spotted on channeled Whatman LK5DF plates, allowed to 
dry for 1 hour and then developed in methylamine, 40%:ethanol, 100%: 
chloroform, 100% (5:18:40) for 80 minutes. The chromatographs were 
allowed to dry overnight, during which time the 3-methoxytyramine 
spot (Rf=OQ93) and the normetanephrine spot (Rf=0.77) became visibleo 
UV light (254 nm) was also used to visualize the spots. The spots 
were then marked, scraped into liquid scintillation vials and the 
compounds were extracted from the silica with Oe5 m1 of acetic acid: 
ethylacetate: (11 20) (3:3:1) for 30 minutes. Ten ml of scintillation 
cocktail (toluene:ethanol (95%), 7:3, containing 0.5% PPO) was added 
to the vials and counted in a Beckman LS 9000 scinti1lation counter 
at an efficiency of 38%. Internal standards were not run routinely, 
because addition of either DA or NE to neostriatal extracts showed 
no significant difference in dpm than that seen in perchloric acid 
and 10 mg% EGTA alone. 
RESULTS 
Short-term Effects of Methamphetamine 
Figure 1 illustrates the effects of multiple toxic doses of 
methamphetamine (15 mg/kg, s.c., every 6 hours for 5 doses) on TH 
activity at 36 hours. As shown previously (Koda and Gibb, 1973; 
Buening and Gibb, 1974; and Kogan et al., 1976), methamphetamine 
induced a significant decrease in neostriatal TH activity (to 59% 
of control). In contrast, there was a slight d~crease or no effect 
in the other nuclei in which TH activity was assayed. Enzymatic 
activity in the olfactory tubercle vias significantly depressed from 
14.8 to 12.7 nmoles tyrosine oxidized/mg protein/hr (a 14% decrease). 
However, methamphetamine induced no change in TH activity in either 
the nucleus accumbens or the median eminence area. 
The differential decreases- in TH activity correlated with NE 
and DA concentrations after the same drug treatment (Figures 2 and 
3). Neostriatal NE and DA were significantly decreased to 32% and 
18% of control, respectively. Catecholamine levels in the olfactory 
tubercle were also reduced (NE to 64% of control; DA to 47% of con-
trol). In the nucleus accumbens, however, the respective neuro-
transmitter concentrations were not significantly altered. 
In order to determine whether methamphetamine caused an effect 
on mesolimbic TH activity prior to 36 hours, time-response relation-
ships were determined. Figure 4 indicates that there was a time-de-
14 
FIG. 1 Effect of methamphetamine (METH) on TH activity in the neo-
striatum, nucleus accumbens, olfactory tubercle and median eminence 
area. Rats were injected with either normal saline (1 mg/kg, s.c.; 
D) or r·iETH (15 mg/kg, s. c.; fill) every 6 hours for 5 doses and 
decapitated 36 hours after the first dose. Numbers inside bars re-
fer to the number of animals per group. Brackets indicate ± S.E.M. 
(*) p<O.05 compared to saline control 






























































































































































































































FIG. 2 Effect of METH on NE levels in the neostriatum, nucleus 
accumbens and olfactory tubercle. Dosage regimen and decapitation 
time are as described in the legend of Figure 1. Numbers inside 
bars refer to the number of animals per group. Brackets indicate ± 
S.E.Mu 










































































































































FIG. 3 Effect of METH on DA levels in the neostriatum, nucleus 
accumbens and olfactory tubercle. Dosage regimen and decapitation 
time are as described in the legend of Figure 1. Numbers inside 
bars refer to the number of animals per group. Brackets indicate ± 
S.E.M. 






















































FIG. 4 Time-dependent effect of ~1ETH on TH activity in the neo-
striatum (.)~ olfactory tubercle ( • ) -and nucleus accumbens 
( 4t). Rats were injected with either normal saline (1 mg/kg, s.c.) 
or ~1ETH (15 mg/kg, s. c.) every 6 hours. To four groups of rats the 
following number of doses were administered: 1, 2, 3 or 5. Con-
trol and treated animals were sacrificed at 3 and 6, 12, 24 and 36 
hours, respectively. The zero time point of each line represents 
the mean of 11-18 control observations. All other points represent 
the mean of 8-16 observations. Brackets indicate ± S.E.M. 
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pendent effect and provides additional support for a differential 
response to methamphetamine administration. TH activity in the ol-
factory tubercle was depressed significantly at the 24-hour and 36-
hour time points by 12% and 18%, respectivelyo In the nucleus ac-
cumbens, TH activity was not significantly different from control 'at 
3, 6, 12, 24 or 36 hours. In contrast, neostriatal TH activity was 
decreased more extensively and at earlier periods than that observed 
in the mesolimbic nuclei to 87, 79, 58 and 46% of control at 3, 12, 
24 and 36 hours, respectively. 
Recent investigations in our laboratory have shO\~n that meth-
amphetamine decreases TPH activity, but does not affect ChAT activ-
ity in the neostriatum (Hotchkiss et ala, 1979). These studies have 
been expanded to include the nucleus accumbens and olfactory tuberclea 
Figure 5 shows time-dependent responses of ChAT, TH and TPH activ-
ities to 5 doses of methamphetamine in the neostriatum, nucleus ac-
cumbens and olfactory tubercle. Table 1 contains the control values 
used to convert the enzyme specific activities to percent control. 
It should be noted that the TH data in Figure 5 is that presented in 
Figure 4, but has been converted to percent control for comparative 
purposes. 
The only significant alteration in ChAT activity occurred in 
the olfactory tubercle (a 9% decrease) at 36 hours. There was no 
difference in ChAT activity compared to control in the nucleus ac-
cumbens or neostriatum at the 3, 6 or 36-hour pointso 
The most significant effect occurred with the serotonergic neur-


























































































































































































































































































































































FIG. 5 Comparison of the time-dependent effect of METH on ChAT 
activity ( .. ), TH activity ( () ) and TPH activity ( ~ ) in the 
neostriatum, nucleus accumbens and olfactory tubercle. Rats were in-
jected with either normal saline (1 mg/kg, s.c.) or METH (15 mg/kg, 
s.c.) every 6 hourso See legend of Figure 4 for decapitation sched-
ule and Table 1 for control values used for the percent conversions. 
The O-hour time point ( to ) represents the control values for all 3 
enzymes in each of the tissue samples assayed. The n values for 
ChAT and TH activities for all tissue samples are the mean of 6-17 
observations. The n values for TPH in the mesolimbic nuclei re-
present 2-3 pooled samples and the mean of 3-6 observationso Brack-
ets indicate ± S.EoMo 
(*) p<O.05 compared to saline control 
(**) p<OoOl compared to saline control 
25 
! z 100 nl 
° (J) 
** 
-; ~ ** :u -50 ~ l> 
-; 





n: 100 l> I-
z nz 
nc 0 Cn u 
~r 50 nl I-
** 
me Z nl(f) 
Z W (f) U 0 0:: 
W 
0... ~-~~ * ~ -i 0 c r mil 
• ChAT ** ** nll> 
o TH :uO 50 o-i 







0 6 12 24 36 
HOURS 
26 
times considered TPH activity was depressed so greatly by metham-
phetamine that the dpm from the treated samples were not twice blank. 
Therefore, it is difficult to make quantitative inferences about how 
much TPH activity remains during and after drug treatment. Qualita-
tively, TPH activity was depressed dramatically at 3 hours after the 
first dose of methamphetamine and stayed depressed thr~ughout the 
time course. In areas where drug treatment had very little effect 
on TH activity (nucleus accumbens and olfactory tubercle), TPH activ-
ity was decreased to 25% of control or lower. It is noteworthy that 
neostriatal TPH activity almost reached its nadir (to 27% of control) 
at 3 hours, whereas the greatest decrease observed in neostriatal TH 
activity (to 46% of control) did not occur until 36 hourso 
Long-te~ Effects of Methamphetamine 
In these experiments, methamphetamine (15 mg/kg, s.co) was ad-
ministered every 6 hours for 5 doses and the TH and TPH activities 
were measured at various times. up to 30 days after the last dose 
(Figure 6). The depression in TPH activity caused by methamphetamine 
at 36 hours (Figure 5) was still significantly decreased 2 days 
after the last injection in the neostriatum, nucleus accumbens and 
olfactory tubercle to 29,41 and 42% of control, respectively. Thir-
ty days after the last injection no recovery of serotonergic enzyme 
activity had occurred in the 3 areas assayed. 
In contrast to the chronic generalized depression of TPH activ-
ity induced by methamphetamine, TH activity in va}~ious brain areas was 
affected differentially. Neostriatal TH activity was decreased sig-
27 
FIG. 6 Chronic effects of METH on TH ( 0 ) and TPH ( e ) activity 
in the neostriatum, nucleus accumbens and olfactory tubercle. Rats 
were injected with either normal saline (lmg/kg, s.c.) or METH {15 
mg/kg, s.c.}. The legend for Figure 1 describes the dosage regimen. 
Animals were decapitated 0.5, 2, 7, 15 and 30 days after the last 
dose of drug. The zero time-point of each line represents the mean 
of 18-27 control observations. These observations at the different 
time-points were not significantly different. The n values for TPH 
activity for the mesolimbic nuclei represent 2-3 pooled samples and 
were 9 for control and ranged from 2-6 for treated animals" All 
other points represent the mean of 6-12 observations. Brackets in-
dicate ± S.E.M. 
{*} p<0.05 compared to saline control 
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nificantly at 0.5 days and this depression persisted with little re-
covery for at least 30 days after the last injection. TH activity in 
the nucleus accumbens decreased gradually in a time-dependent manner 
to only 90% and 80% of control, 15 and 30 days after the last injec-
tion, respectively. In the olfactory tubercle, methamphetamine ini-
tially (0.5 day) caused a 24% depression in TH activity; however, 7 
days after treatment, enzyme activity returned to control values and 
thereafter was significantly decreased to 78% and 79% of control at 
15 and 30 days, respectively. 
Dopamine values measured at 00 5 and 7 days after the last injec-
tion of methamphetamine corroborate the biphasic response observed in 
olfactory tubercle TH activity (Figure 7). In the olfactory tubercle, 
there was a significant difference between control and treated ani-
mals 0.5 and 7 days after the last injection, but the enzyme activ-
ity had increased toward normal by 7 days (25% increase compared to 
the 0.5-day time point, p<O.005). Neostriatal DA concentrations 
were also significantly decreased but the results did not indicate 
a significant biphasic response as seen in the olfactory tubercle 
(to 18% and 24% of control). No significant change in DA in the nu-
cleus accumbens occurred after methamphetamine treatment. 
FIG. 7 Chronic effect of METH on DA levels in the neostriatum, 
nucleus accumbens and olfactory tuber'cle. Rats vlere injected with 
either' normal saline (1 mg/kg, s.c.; D) or METH (15 mg/kg, s.c.; 
30 
~) as described in the legend for Figure 1 and decapitated 0.5 
and 7 days after the last dose of drug. Numbers inside the bars re-
fer to the number of animals per group. Brackets indicate ± SoE.~~. 
(*) p<O.OOl compared to saline control 

















































































































































































































































































































































This descriptive study of the effects of multiple toxic doses 
of methamphetamine on biogenic amine metabolism in the central ner-
vous system of the rat emphasizes the necessity of investigating 
drug-induced changes in several brain regions. Although the rat neo-
striatum and nucleus accumbens appear to be similar anatomically 
(Heimer and Wilson, 1975) and amphetamine and its congeners generally 
inhibit reuptake and cause release of monoamines .(see Holmes and 
Rutledge, 1976)~ the present results indicate a differential effect 
of toxic doses of methamphetamine in these structures. More speci-
fically, the activities of neuronal synthesizing enzymes are dif-
ferentially affected during and after drug administration within in-
dividual brain regions as well as between the different areas in-
vestigated. 
Comparisons of the short-term and long-term effects of meth-
amphetami ne i ndi ca te tha t the serotoner'gi c neurons are more sens i ti ve 
than either the dopaminergic or cholinergic neurons to the neuro-
toxic effects of the drug. Decreases in TH activity and in DA and NE 
levels were more pronounced in the neostriatum than in the mesolimbic 
nuclei or in the median eminence area. In fact, the catecholaminergic 
neurons in the nucleus accumbens and median eminence area appear to 
be resistant to the short-term toxic effects of methamphetamine. 
ChAT activit.y was not altered by drug treatment in the nuclei investi-
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gated, which corroborates McGeer et ala (1974) who reported a lack . 
of effect of methamphetamine on ChAT activity in the neostriatum of 
the rat. 
A generalized effect on the serotonergic neurons did occur, how-
ever, during methamphetamine administr'ation, i.e., TPH activity was 
dramatically decreased in the neostriatum, nucleus accumbens and ol-
factory tubercle to 27% of control or lower within 3 hours after a 
single dose of the drug. These data parallel the decreased conver-
sion of tryptophan to 5-hydroxytryptamine in neostriatal synapto-
somes by methamphetami ne or amphetamine as reported by Knapp et a 1 • 
(1974) and extend the investigations reported earlier by Hotchkiss 
et a 1. (1979). 
The long-term effects of methamphetamine also provide evidence 
for a drug-induced differential modification of biogenic amine meta-
bolism. TH activity in the nucleus accumbens decreased very gradu-
ally over a 3D-day period. In the olfactory tubercle, a biphasic 
response with respect to TH activity and DA levels was observed. 
Neostriatal TH activity was decreased at 0.5 day and remained de-
pressed for up to 3D days after the dosage regimen. In contrast, 
TPH activity was markedly depressed in all three areas for the entire 
30-day time course. 
The decreases observed in TH and TPH activity agree with in-
vestigations measuring the effect of chronic administration of meth-
amphetamine or amphetamine on the levels of different neurotransmit-
tel's. Tonge (1974) admini stered amphetami ne for 3 weeks in the 
dri nki ng "later of rats and found that 36 hours after cessati on of 
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drug both NE and 5-hydroxytryptamine (5-HT) levels were decreased in 
several rat brain regions, including the neostriatum. Chronic admin-
istration of methamphetamine to monkeys induced a decrease in DA in 
the neostriatum but not in the pons-medulla, mid-brain, hypothalamus 
or frontal cortex 24 hours and 3-6 months post treatment (Seiden, 
Fischman, and Schuster, 1975). Ellison, Eison, Huberman, and Daniel 
(1978) administered amphetamine continuously to rats and observed a 
decrease in dopamine levels after 2-5 days of drug treatment and 
demonstrated a decrease in neostriatal TH activity 110 days after 10 
days of continuous treatment. More recently, Trulson and Jacobs 
(1979) reported a decrease in 5-HT and DA in several regions of the 
cat brain 4 to 5 hours after 2 daily injections of amphetamine for 
10 days. 
The differential effects of methamphetamine on dopaminergic and 
serotonergic neurons may be explained by selective uptake of meth-
amphetamine into the respective nerve terminals. A number of in-
vestigators have shown that amphetamine is localized in nerve ter-
minals (Wong, Vanfrank, Horng, and Fuller, 1972; Azzoro, Ziance, and 
Rutledge, 1974; and Jori, Caccia, and Garattini, 1977) and that the 
uptake of low concentrations of 3H-amphetamine into synaptosomes is 
blocked by two different uptake inhibitors, cocaine and desipramine 
(Azzoro et al~, 1974). There is also evidence that the uptake sys-
tem has stereoselectivity. Horn (1973) demonstrated that the nor-
adrenergic terminal sites were more sensitive to changes in the ba-
sic s-phenethylamine structure than were the dopaminergic terminals 
with respect to inhibition of uptake of NE and DA into synaptosomes 
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of rat hypothalamus and neostriatum, respectively. Raiteri, Ber-
tollini, Angelini~ and Levi (1974), referring to Hornls work, sug-
gested that the differential effect of amphetamine in releasing 3H-
monoamines from different brain regions may be due to the less struc-
tural and stereochemical specificity of the uptake sites for DA as 
compared to NE and that such a relationship may provide d-amphetamine 
greater accessibility to dopaminergic storage sites than to nor-
adrenergic storage sites. This difference would permit a higher ac-
cumulation of amphetamine into the dopaminergic terminals. The pre-
sent data provide supportive evidence for diff~rential accessibility 
by comparing the effects of methamphetamine on catecholamine levels 
in the neostriatum and/or olfactory tubercle in which the amount of 
depletion is less for NE than it is for DA (neostriatum, to 32 and 
18% of control, olfactory tubercle, to 64 and 47% of control; levels 
of NE and DA, respectively). 
Perhaps the uptake system for the serotonergic nerve terminals 
is even less sensitive to stereochemical requirements than either of 
the catecholamine terminals leading to a greater accumUlation of 
methamphetamine -j nto serotonergi c systems. Evi dence tha t methamphet-
amine may be taken up into serotonergic terminals comes from recent 
studies indicating that the methamphetamine-induced decrease in TPH 
activity but not in TH activity in the neostriatum is blocked by a 
specific 5-HT uptake inhibitor, fluoxetine (Hotchkiss and Gibb, per-
sonal observations). However, if amphetamine concentrations are mea-
sured in the neostriatum after 6-hydroxydopamine or 5,6-dihydroxy-
tryptamine, only the former neurotoxin decreases the drug concentra-
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tion (Jori et a1., 1977). These observations suggest that amphet-
amine is localized in catecholaminergic not serotonergic terminals 
in the neostriatum. Further studies are needed to clarify these re-' 
sults. 
The lack of a methamphetamine-induced decrease on TH activity 
and catecholamine levels, but not on TPH activity, in the nucleus ac-
cumbens emphasizes the sensitivity of the serotonergic nerve termi-
nals to the neurotoxic effects of this drug. Other investigators 
have also shown that the dopaminergic terminals in the nucleus ac-
cumbens are affected less by amphetamine treatment than are other 
dopaminergic areas of the brain. Kuczenski (1979) reported that am-
phetamine blocked a haloperidol-induced increase in rat neostriatal 
TH activity and DOPAC levels but no blockade occurred in the nu-
cleus accumbens with amphetamine. Ko Eo Moore (personal communica-
tion) has also shown that amphetamine had no significant effect on 
TH activity in the nucleus accumbens. 
In conclusion, we have shown that TH and TPH activities are dif-
ferentially depressed during methamphetamine administration. The de-
crease in enzyme activity occurs more rapidly and more profoundly in 
the serotonergic neurons than in the dopaminergic neurons and per-
sists for at least one month after drug treatment with little, if 
any, recovery of TPH activity. In light of the postulated involve-
ment of the meso1imbic nuclei in paranoid schizophrenia (Stevens, 
1975; Hornykiew;cz, 1978; and Fare1y, et a1., 1978) it is interest-
ing to note that in this animal paradigm the most dramatic altera-
tions induced by methamphetamine in these nuclei occurred in the sero-
37 
tonergic nerve terminals. Inference suggests that the motor and emo-
tional disturbances associated with amphetamine psychosis and para-
noid schizophrenia may be due, in part, to a multiple disruption in 
the synthesis of both catecholamines and 5-HT. 
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